Table 1 Patient demographic data(n = 50)
Characteristics | |
|---|---|
Gender | |
Female | 24(48%) |
Male | 26(52%) |
Disease duration (median; range; months) | 18(1–357) |
PSC | |
No | 37(74%) |
Yes | 13(26%) |
PPC | |
No | 35(70%) |
Yes | 15(30%) |
Manifestation at diagnosis | |
Bloating or ascites or abdominal mass | 48(96%) |
Others | 2(4%) |
Comorbidities | |
ileus | 18(36%) |
anemia | 23(46%) |
hypoalbuminemia | 9(18%) |
Increased levels of Serum tumor maker | |
CEA | 33(66%) |
CA125 | 34(68%) |
CA199 | 27(54%) |
PCI | |
<13 | 2(4%) |
13–26 | 14(28%) |
>26 | 34(68%) |
CCR | |
0,1 | 20(40%) |
2 | 21(42%) |
3 | 9(18%) |
HIPEC | |
No | 9(18%) |
Yes | 41(82%) |
Signet ring cell | |
No | 42(84%) |
Yes | 8(16%) |
Lymph node metastasis | |
No | 43(86%) |
Yes | 7(14%) |
Ki-76 | |
<50 | 32(64%) |
≥ 50 | 18(36%) |
Follow-up time (median; range; months) | 24(12–36) |